NOVACYT S.A. (NCYT) — Interim Results Presentation

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the NOVACYT investor presentation. Throughout this quarter presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time by the q and a tab situated in the right hand corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question received in the meeting itself. However, the company can view all the questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to make the following poll. And for the benefit of those joining us from France, I'd now like to hand you over to Lynn Rees. Good good morning, sir. Thank you very much, and good morning, everyone. And, obviously, thank you for joining us and taking some time out to listen to our interim presentation this morning. I'm presenting to you today myself. I'm now the the CEO at NOVACYT. Been in situation since the May 1. Prior to that, I spent six years at. And prior to that, I was with BBI. So in the industry for twenty odd years plus, done a lot of acquisitions, and looking forward to presenting the results today. Alongside me, we have Steve. Hey. Good morning, everyone. Thanks, Lynn. So, yeah, Steve Gibson. I'm the CFO. I've been with NovaSight now for around seven and a half years. Prior to that, I spent just under twelve years at Hewlett Packard in a variety of different roles. Thank you, Steve. Okay. So just a quick introduction to what it is that we do here at NOVACYT. We're an international molecular group, diagnostics company with a growing portfolio of clinical assays, instrumentation, and research tools. And this is how we're basically structuring the business now as you can see on this slide. We've obviously got t...